Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga; Teresa Freire; Luis Ubillos

doi:10.1002/ijc.30246

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga ^{1, 2} Teresa Freire ^{1, 2} Luis Ubillos ²

1 Institut Pasteur de Montevideo

2 Departamento de inmunobiologia

Type de document :

Article dans une revue

International Journal of Cancer, Wiley, 2016, 139 (9), pp.2144. 〈10.1002/ijc.30246〉

Domaine :

Sciences du Vivant [q-bio]

Liste complète des métadonnées

https://hal-riip.archives-ouvertes.fr/pasteur-01499032
Contributeur : Mariella Botta <>
Soumis le : jeudi 30 mars 2017 - 20:20:24
Dernière modification le : mercredi 21 février 2018 - 17:10:02

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Identifiants

Collections

Citation

Exporter

Métriques

17

Contact

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Identifiants

Collections

Citation

Exporter

Partager

Métriques

17

Contact